Myocardial Injury Clinical Trial
Official title:
Perioperative Endothelial Dysfunction in Patients Undergoing Non-cardiac Surgery
More than one in 100 otherwise healthy patients undergoing non-cardiac surgery will die within 30 days post-operatively, and of these patients 45% will die from vascular causes such as myocardial infarction. The pathogenesis of perioperative myocardial infarction is complex and to date not fully elucidated. The physiological stress response associated with the surgical procedure is believed to be central in the development of perioperative cardiovascular complications. Surgery initiates systemic inflammation, hypercoagulability and increases the production of catecholamines and cortisol. These drastic systemic changes lead to a state of myocardial oxygen supply-demand mismatch, which added to acute endothelial dysfunction and ruptures of vulnerable plaques, may result in myocardial injury. The endothelium is a regulator of vascular homeostasis, vascular tone and structure and exerts anticoagulant, antiplatelet and fibrinolytic properties. Endothelial dysfunction is characterized by a decreased vascular bioavailability of nitric oxide probably due to an increased degradation of nitric oxide via its interaction with locally produced reactive oxygen species. No clinical studies have investigated whether peri- and postoperative endothelial dysfunction is associated with an increased risk of perioperative myocardial injury. Endothelial dysfunction may be a key element in the development of perioperative myocardial injury. The aim of this observational clinical study is to closely examine the endothelial function and its dynamics in the early postoperative period.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03940651 -
Cardiac and Renal Biomarkers in Arthroplasty Surgery
|
Phase 4 | |
Completed |
NCT01688648 -
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT04794062 -
Myocardial Injury and Quality of Life After COVID-19
|
||
Recruiting |
NCT04750616 -
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
|
Phase 2 | |
Recruiting |
NCT04615871 -
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
|
Phase 2 | |
Withdrawn |
NCT04139655 -
Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study
|
N/A | |
Completed |
NCT05691764 -
Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery
|
N/A | |
Completed |
NCT04436016 -
PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery
|
Phase 4 | |
Completed |
NCT05748691 -
Switching From Cardiac Troponin I to T
|
||
Completed |
NCT03338504 -
Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
|
||
Recruiting |
NCT03013634 -
Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation
|
N/A | |
Completed |
NCT00007358 -
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
|
N/A | |
Recruiting |
NCT05714618 -
MR Evidence of Cardiac Inflammation Post-Stroke
|
||
Recruiting |
NCT04624503 -
Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19
|
||
Active, not recruiting |
NCT03339180 -
Cardiac Injury in Patients With Influenza
|
||
Completed |
NCT03010839 -
Cardiopulmonary Protective Effects of Modified Remote Ischaemic Preconditioning in Mitral Valve Replacement Surgery
|
N/A | |
Recruiting |
NCT04743765 -
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
|
N/A | |
Enrolling by invitation |
NCT03253835 -
Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage
|
||
Completed |
NCT00817791 -
Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery
|
N/A | |
Completed |
NCT04149314 -
The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery
|
N/A |